This Atlanta-based activist is helping hundreds of same-gender loving men learn to thrive in their lives.
We need to be able to hear and amplify the voices that have been ignored, marginalized, or outright silenced.
The CD11+c cell is on the frontline of the body’s response to HIV, and new research provides promise for treatment.
Two men from very different worlds are changing how Miami’s Latinx community accesses Prep — in a city where 5 percent of people are living with HIV. That's more than New York, L.A., or San Francisco.
"People are dying!" the Congresswoman said, calling on the CEO of Gilead to improve access to PrEP in order to end the HIV epidemic.
Prosecutors claim that Teva, Pfizer, Novartis, and Mylan, among others, schemed their way to higher profits.
The advocacy group is singlehandedly going against Gilead and the CDC to release its hold or PrEP.
